©The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Respirol. Mar 28, 2016; 6(1): 14-23
Published online Mar 28, 2016. doi: 10.5320/wjr.v6.i1.14
Published online Mar 28, 2016. doi: 10.5320/wjr.v6.i1.14
Prognostic scoring systems for clinical course and survival in idiopathic pulmonary fibrosis
Ermanno Puxeddu, Paola Rogliani, Respiratory Medicine, Department of Systems Medicine, University of Rome “Tor Vergata”, 00133 Rome, Italy
Author contributions: Both Puxeddu E and Rogliani P performed literature review and wrote the paper.
Conflict-of-interest statement: Rogliani P and Puxeddu E have no conflict of interest to declare.
Correspondence to: Paola Rogliani, MD, Respiratory Medicine, Department of Systems Medicine, University of Rome “Tor Vergata”, Via Montpellier 1, 00133 Rome, Italy. paola.rogliani@uniroma2.it
Telephone: +39-6-20903616
Received: September 23, 2015
Peer-review started: October 3, 2015
First decision: November 24, 2015
Revised: December 22, 2015
Accepted: January 29, 2016
Article in press: January 31, 2016
Published online: March 28, 2016
Processing time: 184 Days and 10.1 Hours
Peer-review started: October 3, 2015
First decision: November 24, 2015
Revised: December 22, 2015
Accepted: January 29, 2016
Article in press: January 31, 2016
Published online: March 28, 2016
Processing time: 184 Days and 10.1 Hours
Core Tip
Core tip: Idiopathic pulmonary fibrosis (IPF) is the most common and rapidly lethal among interstitial lung disease. Its clinical course is highly variable and estimating prognosis of patients with IPF is extremely difficult with important impacts on the best clinical management of patients, including the referral of patients for lung transplantation. In this review article we evaluate relevant studies published on this subject and examine the variety of proposed prognostic predictors along with staging systems.